• FDA Approves AstraZeneca And Sanofi's Beyfortus To Protect Infants Against RSV Disease

    Source: NASDAQ US Markets / 17 Jul 2023 22:07:25   America/New_York

    (RTTNews) - The U.S. Food and Drug Administration approved AstraZeneca (AZN, AZN.L) and Sanofi's Beyfortus or nirsevimab for the prevention of respiratory syncytial virus lower respiratory tract disease in infants. The new drug will be available in the US ahead of the upcoming 20 https://www.nasdaq.com/articles/fda-approves-astrazeneca-and-sanofis-beyfortus-to-protect-infants-against-rsv-disease
Share on,